Back

Lexaria Bioscience receives USD$2.6 million Australian tax rebate

Verifying
  • Lexaria Bioscience Corp. received a cash rebate from the Australian Tax Office.
  • USD$2.6 million, equivalent to AUD$3.67 million, was awarded to the company.
  • The rebate covered Lexaria’s 2025 human study conducted in Australia.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.